Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study

BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. METHODS This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resecti...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 119; no. 24; pp. 4242 - 4248
Main Authors Amit, Moran, Yen, Tzu‐Chen, Liao, Chun‐Ta, Chaturvedi, Pankaj, Agarwal, Jai Prakash, Kowalski, Luiz P., Ebrahimi, Ardalan, Clark, Jonathan R., Kreppel, Matthias, Zöller, Joachim, Fridman, Eran, Bolzoni, Villaret A., Shah, Jatin P., Binenbaum, Yoav, Patel, Snehal G., Gil, Ziv
Format Journal Article
LanguageEnglish
Published Hoboken, NJ Wiley-Blackwell 15.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. METHODS This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003). RESULTS Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5‐year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease‐specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer‐specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3‐0.6). CONCLUSIONS The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. Cancer 2013;119:4242–4248. © 2013 American Cancer Society. The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality.
AbstractList An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.BACKGROUNDAn association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.This was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003).METHODSThis was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003).Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6).RESULTSPatients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6).The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy.CONCLUSIONSThe survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy.
An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. This was a retrospective, longitudinal, international, population-based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003). Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5-year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease-specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer-specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3-0.6). The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy.
The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality.
BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established. METHODS This was a retrospective, longitudinal, international, population‐based study of 2738 patients who underwent resection of OCSCC during 2 different decades. Characteristics of patients from 7 international cancer centers who received treatment between 1990 and 2000 (group A; n = 735) were compared with patients who received treatment between 2001 and 2011 (group B; n = 2003). RESULTS Patients in group B had more advanced tumors and tended to develop distant metastases more frequently than patients in group A (P = .005). More group B patients underwent selective neck dissection and received adjuvant radiotherapy (P < .001). Outcome analysis revealed a significant improvement in 5‐year overall survival, from 59% for group A to 70% for group B (P < .001). There was also a significant improvement in disease‐specific survival associated with operations performed before and after 2000 (from 69% to 81%, respectively; P < .001). Surgery after 2000, negative margins, adjuvant treatment, and early stage disease were independent predictors of a better outcome in multivariate analysis. The decade of treatment was an independent prognostic factor for cancer‐specific mortality (hazard ratio, 0.42; 95% confidence interval, 0.3‐0.6). CONCLUSIONS The survival rate of patients with OCSCC improved significantly during the past 2 decades despite older age, more advanced disease stage, and a higher rate of distant metastases. The current results suggest that the prognosis for patients with OCSCC has improved over time, presumably because of advances in imaging and therapy. Cancer 2013;119:4242–4248. © 2013 American Cancer Society. The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of distant metastases. The decade of treatment is identified as an independent prognostic factor for outcome with a hazard ratio of 0.42 for cancer‐specific mortality.
Author Kreppel, Matthias
Gil, Ziv
Kowalski, Luiz P.
Ebrahimi, Ardalan
Shah, Jatin P.
Zöller, Joachim
Fridman, Eran
Binenbaum, Yoav
Agarwal, Jai Prakash
Chaturvedi, Pankaj
Yen, Tzu‐Chen
Amit, Moran
Bolzoni, Villaret A.
Clark, Jonathan R.
Liao, Chun‐Ta
Patel, Snehal G.
Author_xml – sequence: 1
  givenname: Moran
  surname: Amit
  fullname: Amit, Moran
  organization: Israel Institute of Technology
– sequence: 2
  givenname: Tzu‐Chen
  surname: Yen
  fullname: Yen, Tzu‐Chen
  organization: Chang Gung Memorial Hospital
– sequence: 3
  givenname: Chun‐Ta
  surname: Liao
  fullname: Liao, Chun‐Ta
  organization: Chang Gung Memorial Hospital
– sequence: 4
  givenname: Pankaj
  surname: Chaturvedi
  fullname: Chaturvedi, Pankaj
  organization: Tata Memorial Hospital
– sequence: 5
  givenname: Jai Prakash
  surname: Agarwal
  fullname: Agarwal, Jai Prakash
  organization: Tata Memorial Hospital
– sequence: 6
  givenname: Luiz P.
  surname: Kowalski
  fullname: Kowalski, Luiz P.
  organization: Hospital AC Camargo
– sequence: 7
  givenname: Ardalan
  surname: Ebrahimi
  fullname: Ebrahimi, Ardalan
  organization: Royal Prince Alfred Hospital
– sequence: 8
  givenname: Jonathan R.
  surname: Clark
  fullname: Clark, Jonathan R.
  organization: Royal Prince Alfred Hospital
– sequence: 9
  givenname: Matthias
  surname: Kreppel
  fullname: Kreppel, Matthias
  organization: University of Cologne
– sequence: 10
  givenname: Joachim
  surname: Zöller
  fullname: Zöller, Joachim
  organization: University of Cologne
– sequence: 11
  givenname: Eran
  surname: Fridman
  fullname: Fridman, Eran
  organization: Israel Institute of Technology
– sequence: 12
  givenname: Villaret A.
  surname: Bolzoni
  fullname: Bolzoni, Villaret A.
  organization: University of Brescia
– sequence: 13
  givenname: Jatin P.
  surname: Shah
  fullname: Shah, Jatin P.
  organization: Memorial Sloan Kettering Cancer Center
– sequence: 14
  givenname: Yoav
  surname: Binenbaum
  fullname: Binenbaum, Yoav
  organization: Israel Institute of Technology
– sequence: 15
  givenname: Snehal G.
  surname: Patel
  fullname: Patel, Snehal G.
  organization: Memorial Sloan Kettering Cancer Center
– sequence: 16
  givenname: Ziv
  surname: Gil
  fullname: Gil, Ziv
  organization: Israel Institute of Technology
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28032833$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24114787$$D View this record in MEDLINE/PubMed
BookMark eNp9kd1rFDEUxYO02G31xT9A8iIUYWo-m4xvZfGjUCqIgm9DJnuDkZlkm2Sm7H9vprsqlOJTyOF3Dvfec4qOQgyA0CtKLigh7J0NNl0wzaV6hlaUtKohVLAjtCKE6EYK_uMEneb8q34Vk_w5OmGCUqG0WqF0PW5TnGGEULAPOE9p9rMZcHR4a4qvcsb3vvzEMVXVmtmXHc53kxnjlLGFYRGT9SGO5j2-CjWkQArVGsNiiMNg-uotfgacy7TZvUDHzgwZXh7eM_T944dv68_NzZdP1-urm8ZySlRjtOVW6p4BEU5Qwtq25dJtVA-sV8ww6y57zTUwooWwjIMkknPnxMZJaAU_Q-f73Lrg3QS5dKPPy8AmQJ29o-JSUiVbRSv6-oBO_Qibbpv8aNKu-3OnCrw5ACZbM7hkgvX5H6cJrwXwyr3dczbFnBO4vwgl3VJWt5TVPZRVYfIItr48HK4k44enLXRvufcD7P4T3q1v11_3nt-Hmqgz
CODEN CANCAR
CitedBy_id crossref_primary_10_1038_s41415_019_0523_0
crossref_primary_10_1002_cam4_1216
crossref_primary_10_1097_CEJ_0000000000000932
crossref_primary_10_1111_ans_13512
crossref_primary_10_1002_cncy_22249
crossref_primary_10_1016_j_identj_2024_09_035
crossref_primary_10_1016_j_radonc_2019_01_014
crossref_primary_10_1177_0194599820949223
crossref_primary_10_1002_lary_27315
crossref_primary_10_1038_s41598_024_56694_y
crossref_primary_10_1177_1073274820920727
crossref_primary_10_1016_j_radonc_2020_08_013
crossref_primary_10_1111_cas_16028
crossref_primary_10_1002_adbi_202300162
crossref_primary_10_5125_jkaoms_2022_48_5_284
crossref_primary_10_1016_j_oraloncology_2016_12_006
crossref_primary_10_1111_odi_13933
crossref_primary_10_1016_j_clon_2019_05_013
crossref_primary_10_4103_ijc_IJC_445_17
crossref_primary_10_1016_j_oraloncology_2021_105451
crossref_primary_10_1089_cbr_2019_2907
crossref_primary_10_1002_hed_25622
crossref_primary_10_20396_bjos_v22i00_8668473
crossref_primary_10_1007_s12672_025_01998_2
crossref_primary_10_1016_j_oraloncology_2019_02_001
crossref_primary_10_1111_odi_13147
crossref_primary_10_1111_odi_14353
crossref_primary_10_1016_j_ijrobp_2018_09_013
crossref_primary_10_1038_s41379_019_0426_2
crossref_primary_10_1016_j_cps_2016_06_001
crossref_primary_10_1016_j_prp_2021_153474
crossref_primary_10_1002_osi2_1201
crossref_primary_10_1002_hed_24589
crossref_primary_10_1016_j_suronc_2025_102213
crossref_primary_10_1002_hed_24740
crossref_primary_10_1016_j_oraloncology_2015_10_012
crossref_primary_10_1002_hed_26487
crossref_primary_10_1002_hed_24507
crossref_primary_10_5897_JCREO2023_0184
crossref_primary_10_5301_tj_5000425
crossref_primary_10_1016_j_eujim_2020_101162
crossref_primary_10_1002_hed_27748
crossref_primary_10_3892_mco_2017_1276
crossref_primary_10_1007_s00784_018_2424_z
crossref_primary_10_1016_j_ijom_2021_05_020
crossref_primary_10_1016_j_compbiolchem_2025_108348
crossref_primary_10_1016_j_oooo_2021_08_021
crossref_primary_10_2147_CMAR_S272498
crossref_primary_10_1002_cncr_31531
crossref_primary_10_1002_hed_24759
crossref_primary_10_1016_j_oraloncology_2015_10_009
crossref_primary_10_1016_j_oraloncology_2023_106608
crossref_primary_10_1097_MOO_0000000000000039
crossref_primary_10_3390_cancers13225763
crossref_primary_10_3390_diagnostics11061105
crossref_primary_10_1007_s11282_020_00440_3
crossref_primary_10_1016_j_amjoto_2020_102885
crossref_primary_10_21037_ajo_22_20
crossref_primary_10_1016_j_oraloncology_2021_105641
crossref_primary_10_1177_01455613231170705
crossref_primary_10_3390_ijerph18116012
crossref_primary_10_17779_KAOMP_2020_44_3_003
crossref_primary_10_1002_ohn_689
crossref_primary_10_1001_jamaoto_2018_2421
crossref_primary_10_1002_cre2_519
crossref_primary_10_1007_s00520_014_2155_x
crossref_primary_10_1016_j_oraloncology_2016_07_004
crossref_primary_10_1002_hed_24320
crossref_primary_10_1177_0300060520934254
crossref_primary_10_1002_jcp_29744
crossref_primary_10_1016_j_humpath_2020_07_018
crossref_primary_10_1111_jop_12308
crossref_primary_10_12968_denu_2018_45_3_197
crossref_primary_10_1111_jop_12306
crossref_primary_10_1007_s00405_016_4219_7
crossref_primary_10_1016_j_jormas_2023_101713
crossref_primary_10_32635_2176_9745_RBC_2022v68n1_1584
crossref_primary_10_1016_j_oraloncology_2020_104661
crossref_primary_10_1089_dna_2019_5109
crossref_primary_10_1016_j_oraloncology_2017_09_005
crossref_primary_10_1016_j_oraloncology_2021_105371
crossref_primary_10_3390_jcm12041704
crossref_primary_10_1111_jop_12373
crossref_primary_10_1007_s00432_015_2061_8
crossref_primary_10_15448_1980_6108_2021_1_41124
crossref_primary_10_1016_j_bbrc_2017_01_170
crossref_primary_10_1016_j_bjorl_2022_07_001
crossref_primary_10_2147_CMAR_S477791
crossref_primary_10_1001_jamanetworkopen_2021_7083
crossref_primary_10_1016_j_jcms_2018_12_005
crossref_primary_10_1111_apm_12507
crossref_primary_10_1111_odi_13583
crossref_primary_10_1016_j_gene_2020_145283
crossref_primary_10_1245_s10434_015_5070_6
crossref_primary_10_1016_j_jcms_2016_06_007
crossref_primary_10_1007_s12285_018_0152_7
crossref_primary_10_1016_j_drup_2018_09_001
crossref_primary_10_3390_curroncol31010011
crossref_primary_10_1002_hed_25355
crossref_primary_10_1002_hed_24829
crossref_primary_10_3389_fgene_2022_947551
crossref_primary_10_3389_fonc_2019_00339
crossref_primary_10_3390_jcm8010033
crossref_primary_10_1049_syb2_12113
crossref_primary_10_1159_000540977
crossref_primary_10_1111_jcmm_17728
crossref_primary_10_1111_odi_13513
crossref_primary_10_1016_j_cden_2017_08_007
crossref_primary_10_1177_0300060519897187
crossref_primary_10_1002_lary_26632
crossref_primary_10_1002_lary_27720
crossref_primary_10_17650_2222_1468_2022_12_3_28_36
crossref_primary_10_3892_mco_2017_1518
crossref_primary_10_1016_j_joms_2019_03_007
crossref_primary_10_1186_s12903_025_05694_z
crossref_primary_10_1016_j_joms_2016_07_005
crossref_primary_10_1016_j_bbrc_2024_150421
crossref_primary_10_3390_cancers14153588
crossref_primary_10_1002_hed_24276
crossref_primary_10_1007_s13193_023_01712_0
crossref_primary_10_18632_oncotarget_3768
crossref_primary_10_1186_s12885_018_4136_9
crossref_primary_10_1016_j_jormas_2024_102166
Cites_doi 10.1016/j.oraloncology.2008.05.017
10.1016/j.ijrobp.2010.04.031
10.1093/jnci/91.24.2081
10.1200/JCO.2011.35.7301
10.1002/cncr.11630
10.1002/cncr.22882
10.1002/bjs.4874
10.1111/j.1600-0714.2009.00797.x
10.1016/j.oraloncology.2011.03.024
10.1016/j.oraloncology.2012.02.010
10.1016/j.oraloncology.2006.10.001
10.1002/cncr.25834
10.1002/cncr.24631
10.1016/j.canrad.2012.06.005
10.1186/1471-2407-6-28
10.1200/JCO.2009.27.4498
10.1177/000348941212100606
10.1200/JCO.2010.31.7883
10.3322/caac.20073
10.1001/archotol.134.5.536
10.1002/hed.21886
10.1016/j.oraloncology.2012.09.006
10.3322/caac.20121
10.1002/hed.2880120604
10.1002/cncr.25087
10.1097/COC.0b013e3181f4759c
ContentType Journal Article
Copyright 2013 American Cancer Society
2015 INIST-CNRS
2013 American Cancer Society.
Copyright_xml – notice: 2013 American Cancer Society
– notice: 2015 INIST-CNRS
– notice: 2013 American Cancer Society.
CorporateAuthor The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
CorporateAuthor_xml – name: The International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
– name: International Consortium for Outcome Research (ICOR) in Head and Neck Cancer
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/cncr.28357
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 4248
ExternalDocumentID 24114787
28032833
10_1002_cncr_28357
CNCR28357
Genre article
Research Support, U.S. Gov't, Non-P.H.S
Multicenter Study
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1CY
1L6
1OC
24P
29B
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AARRQ
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEIGN
AEIMD
AENEX
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AGNAY
AHBTC
AIACR
AIAGR
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LMP
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Z0Y
ZGI
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGYGG
CITATION
.GJ
31~
3O-
AAQOH
ACCFJ
AEEZP
AEQDE
AFFNX
AGHNM
AI.
AIWBW
AJBDE
C1A
HF~
H~9
IQODW
J5H
N4W
NEJ
OHT
RSU
VH1
WHG
Y6R
YQJ
ZXP
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3107-a8c3c58b2e04f410299935fd7be2b72a2cf6b838e20844c23e50533ff4df5e943
IEDL.DBID DR2
ISSN 0008-543X
1097-0142
IngestDate Fri Jul 11 12:07:15 EDT 2025
Mon Jul 21 05:50:51 EDT 2025
Wed Apr 02 07:20:27 EDT 2025
Tue Jul 01 04:09:09 EDT 2025
Thu Apr 24 22:56:29 EDT 2025
Wed Jan 22 16:38:09 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Keywords Human
margins
Stomatology
Malignant tumor
Oral squamous cell carcinoma
Survival
Oral cavity
squamous
Cancerology
Oral cavity disease
time
trends
Cancer
International
oral cavity
survival
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
2013 American Cancer Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3107-a8c3c58b2e04f410299935fd7be2b72a2cf6b838e20844c23e50533ff4df5e943
Notes We thank Esther Eshkol for editorial assistance.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.28357
PMID 24114787
PQID 1465175971
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1465175971
pubmed_primary_24114787
pascalfrancis_primary_28032833
crossref_primary_10_1002_cncr_28357
crossref_citationtrail_10_1002_cncr_28357
wiley_primary_10_1002_cncr_28357_CNCR28357
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 15 December 2013
PublicationDateYYYYMMDD 2013-12-15
PublicationDate_xml – month: 12
  year: 2013
  text: 15 December 2013
  day: 15
PublicationDecade 2010
PublicationPlace Hoboken, NJ
PublicationPlace_xml – name: Hoboken, NJ
– name: United States
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 2013
Publisher Wiley-Blackwell
Publisher_xml – name: Wiley-Blackwell
References 2009; 45
2012; 121
1990; 12
2011; 117
2013; 49
2011
2011; 80
2011; 61
2006; 6
2011; 34
2012; 16
2012; 34
2012; 32
2003; 98
2009; 115
2010; 60
2009; 11
2010; 116
2010; 28
2007; 110
2005; 92
2011; 47
2012; 48
2008; 134
2007; 43
1999; 91
2011; 29
2009; 38
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
Rampino M (e_1_2_7_10_1) 2012; 32
Howlader N (e_1_2_7_4_1) 2011
American Lung Association (e_1_2_7_3_1) 2011
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_23_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
Gil Z (e_1_2_7_15_1) 2009; 11
O'Neill M (e_1_2_7_18_1) 2011; 34
References_xml – year: 2011
– volume: 134
  start-page: 536
  year: 2008
  end-page: 538
  article-title: Consensus statement on the classification and terminology of neck dissection
  publication-title: Arch Otolaryngol Head Neck Surg.
– volume: 45
  start-page: 394
  year: 2009
  end-page: 401
  article-title: Current concepts in management of oral cancer—surgery
  publication-title: Oral Oncol.
– volume: 110
  start-page: 1033
  year: 2007
  end-page: 1041
  article-title: Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study
  publication-title: Cancer.
– volume: 28
  start-page: 2996
  year: 2010
  end-page: 3001
  article-title: Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02
  publication-title: J Clin Oncol.
– volume: 47
  start-page: 522
  year: 2011
  end-page: 527
  article-title: Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients—a quality of life analysis
  publication-title: Oral Oncol.
– volume: 116
  start-page: 2635
  year: 2010
  end-page: 2644
  article-title: Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)‐related and HPV‐unrelated sites in a multicultural population: the British Columbia experience
  publication-title: Cancer.
– volume: 49
  start-page: 255
  year: 2013
  end-page: 260
  article-title: Postoperative intensity‐modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure
  publication-title: Oral Oncol.
– volume: 11
  start-page: 296
  year: 2009
  end-page: 300
  article-title: Contemporary management of head and neck cancers
  publication-title: Isr Med Assoc J.
– volume: 92
  start-page: 1008
  year: 2005
  end-page: 1013
  article-title: Improvement in survival following surgery for colorectal cancer
  publication-title: Br J Surg.
– volume: 117
  start-page: 2917
  year: 2011
  end-page: 2925
  article-title: Nodal yield and survival in oral squamous cancer: defining the standard of care
  publication-title: Cancer.
– volume: 16
  start-page: 601
  year: 2012
  end-page: 603
  article-title: Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity
  publication-title: Cancer Radiother.
– volume: 115
  start-page: 5700
  year: 2009
  end-page: 5710
  article-title: Lymph node density is a significant predictor of outcome in patients with oral cancer
  publication-title: Cancer.
– volume: 48
  start-page: 747
  year: 2012
  end-page: 752
  article-title: Intensity‐modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity
  publication-title: Oral Oncol.
– volume: 80
  start-page: 1412
  year: 2011
  end-page: 1422
  article-title: Intensity‐modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control
  publication-title: Int J Radiat Oncol Biol Phys.
– volume: 38
  start-page: 657
  year: 2009
  end-page: 662
  article-title: The prognostic significance of histological features in oral squamous cell carcinoma
  publication-title: J Oral Pathol Med.
– volume: 6
  start-page: 28
  year: 2006
  article-title: A meta‐analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck [serial online]
  publication-title: BMC Cancer.
– volume: 32
  start-page: 195
  year: 2012
  end-page: 199
  article-title: Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer
  publication-title: Anticancer Res.
– volume: 121
  start-page: 395
  year: 2012
  end-page: 401
  article-title: Long‐term quality of life in young adults treated for oral cavity squamous cell cancer
  publication-title: Ann Otol Rhinol Laryngol.
– volume: 98
  start-page: 1179
  year: 2003
  end-page: 1187
  article-title: Craniofacial surgery for malignant skull base tumors: report of an international collaborative study
  publication-title: Cancer.
– volume: 61
  start-page: 212
  year: 2011
  end-page: 236
  article-title: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
  publication-title: CA Cancer J Clin.
– volume: 60
  start-page: 277
  year: 2010
  end-page: 300
  article-title: Cancer statistics, 2010
  publication-title: CA Cancer J Clin.
– volume: 29
  start-page: 3503
  year: 2011
  end-page: 3509
  article-title: Population‐based study of competing mortality in head and neck cancer
  publication-title: J Clin Oncol.
– volume: 29
  start-page: 1488
  year: 2011
  end-page: 1494
  article-title: Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years
  publication-title: J Clin Oncol.
– volume: 34
  start-page: 1212
  year: 2012
  end-page: 1217
  article-title: Improvement in survival during the past 4 decades among patients with anterior skull base cancer
  publication-title: Head Neck.
– volume: 43
  start-page: 780
  year: 2007
  end-page: 784
  article-title: The clinical significance of the positive surgical margin in oral cancer
  publication-title: Oral Oncol.
– volume: 91
  start-page: 2081
  year: 1999
  end-page: 2086
  article-title: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced‐stage oropharynx carcinoma
  publication-title: J Natl Cancer Inst.
– volume: 34
  start-page: 478
  year: 2011
  end-page: 482
  article-title: Posttreatment quality‐of‐life assessment in patients with head and neck cancer treated with intensity‐modulated radiation therapy
  publication-title: Am J Clin Oncol.
– volume: 12
  start-page: 470
  year: 1990
  end-page: 475
  article-title: Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome
  publication-title: Head Neck.
– ident: e_1_2_7_14_1
  doi: 10.1016/j.oraloncology.2008.05.017
– ident: e_1_2_7_26_1
  doi: 10.1016/j.ijrobp.2010.04.031
– ident: e_1_2_7_8_1
  doi: 10.1093/jnci/91.24.2081
– ident: e_1_2_7_21_1
  doi: 10.1200/JCO.2011.35.7301
– ident: e_1_2_7_6_1
  doi: 10.1002/cncr.11630
– ident: e_1_2_7_7_1
  doi: 10.1002/cncr.22882
– ident: e_1_2_7_31_1
  doi: 10.1002/bjs.4874
– ident: e_1_2_7_30_1
  doi: 10.1111/j.1600-0714.2009.00797.x
– ident: e_1_2_7_17_1
  doi: 10.1016/j.oraloncology.2011.03.024
– ident: e_1_2_7_25_1
  doi: 10.1016/j.oraloncology.2012.02.010
– ident: e_1_2_7_29_1
  doi: 10.1016/j.oraloncology.2006.10.001
– ident: e_1_2_7_23_1
  doi: 10.1002/cncr.25834
– volume-title: Trends in Tobacco Use
  year: 2011
  ident: e_1_2_7_3_1
– ident: e_1_2_7_20_1
  doi: 10.1002/cncr.24631
– ident: e_1_2_7_11_1
  doi: 10.1016/j.canrad.2012.06.005
– ident: e_1_2_7_9_1
  doi: 10.1186/1471-2407-6-28
– volume: 32
  start-page: 195
  year: 2012
  ident: e_1_2_7_10_1
  article-title: Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer
  publication-title: Anticancer Res.
– ident: e_1_2_7_28_1
  doi: 10.1200/JCO.2009.27.4498
– ident: e_1_2_7_16_1
  doi: 10.1177/000348941212100606
– ident: e_1_2_7_22_1
  doi: 10.1200/JCO.2010.31.7883
– ident: e_1_2_7_19_1
  doi: 10.3322/caac.20073
– ident: e_1_2_7_13_1
  doi: 10.1001/archotol.134.5.536
– ident: e_1_2_7_12_1
  doi: 10.1002/hed.21886
– volume-title: SEER Cancer Statistics Review, 1975–2008
  year: 2011
  ident: e_1_2_7_4_1
– ident: e_1_2_7_24_1
  doi: 10.1016/j.oraloncology.2012.09.006
– ident: e_1_2_7_2_1
  doi: 10.3322/caac.20121
– volume: 11
  start-page: 296
  year: 2009
  ident: e_1_2_7_15_1
  article-title: Contemporary management of head and neck cancers
  publication-title: Isr Med Assoc J.
– ident: e_1_2_7_27_1
  doi: 10.1002/hed.2880120604
– ident: e_1_2_7_5_1
  doi: 10.1002/cncr.25087
– volume: 34
  start-page: 478
  year: 2011
  ident: e_1_2_7_18_1
  article-title: Posttreatment quality‐of‐life assessment in patients with head and neck cancer treated with intensity‐modulated radiation therapy
  publication-title: Am J Clin Oncol.
  doi: 10.1097/COC.0b013e3181f4759c
SSID ssj0007253
Score 2.4698107
Snippet BACKGROUND An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not...
The survival rate of patients with oral cavity cancer has improved significantly during the past 2 decades despite higher stage disease, and a higher rate of...
An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4242
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - radiotherapy
Carcinoma, Squamous Cell - surgery
Cooperative Behavior
Head and Neck Neoplasms - mortality
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - radiotherapy
Head and Neck Neoplasms - surgery
Humans
International Cooperation
Longitudinal Studies
margins
Medical sciences
Middle Aged
Mouth - diagnostic imaging
Mouth - surgery
Mouth Neoplasms - mortality
Mouth Neoplasms - pathology
Mouth Neoplasms - radiotherapy
Mouth Neoplasms - surgery
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
oral cavity
Otorhinolaryngology. Stomatology
Outcome Assessment (Health Care)
Prognosis
Radiography
Radionuclide Imaging
Radiotherapy, Adjuvant - methods
Retrospective Studies
squamous
Squamous Cell Carcinoma of Head and Neck
survival
time
trends
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Young Adult
Title Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.28357
https://www.ncbi.nlm.nih.gov/pubmed/24114787
https://www.proquest.com/docview/1465175971
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB7Egwji-1EfJaIXha3dPLpb8SLFIoIeRKEXWZI0AVG32m09-Oud2d22VkTQ27JM9jGZSb6ZJN8AHIZeibq3OpDd0Acy8jrQvmkwSomtUVpr7imhf33TuLyXVx3VmYGz0VmYgh9inHAjz8jHa3JwbbKTCWmoTW2_RmxhdJScNmsRIrqdcEdFvKSgrMeBkqIz5iblJ5OmU7PRwqvOUDG-qGjxE-ScRrD5FNRegofRxxc7T55qw4Gp2Y9vvI7__btlWCyxKTsvjGkFZly6CnPX5er7GvSLDESeUGSPKcuGOM6gpbKeZyU_a8Yoscvo2D-zmupSsOxtqCm_wGiNAG_28WG9F33KzlP2-DUfyb7Y5LtjOfHtOty3L-5al0FZsyGwCBSjQMdWWBUb7urSS0QvCECF8t3IOG4irrn1DROL2PF6LKXlwik6Dey97HrlmlJswGzaS90WMISSDYFzuOINI3UcGYvDh-liPEqMP5GowNGo7xJbEppTXY3npKBi5gkpMcmVWIGDsexrQePxo1R1ygTGolTCCyXwlfsjm0jQDUlvOnWoQoqgFCKxZhRWYLMwlklriUEnDowVOM67_JcvSFo3rdv8avsvwjswz6lMR8iDUO3C7KA_dHsIlgammjvFJ661EhY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5BkQoSAloKpEDrqr1QadOsH_GGWxVRpY_kULVSbivbsaWosCnZhAO_vjPebdKgCgluq9V4H-MZ-5ux_Q3AQRqUaAVnEjlKQyJ1MIkJHYtRSuasMsbwQAn9_qDdu5ZnQzWs9-bQWZiKH2KRcCPPiOM1OTglpI-WrKGucNMm0YXpp_CMSnrHiOpyyR6leU1C2coSJcVwwU7Kj5ZtV-ajl7emRNWEqqbFY6BzFcPGSejkdVVptYzchbT35KY5n9mm-_0Hs-N__98beFXDU3Zc2dMGPPHFJqz36wX4tzCtkhAxp8jGBSvnONSgsbJJYDVFa8kot8vo5D9zhkpTsPLn3FCKgdEyAd6c4sMmP8xXdlyw8cOUJHtglr88i9y3W3B98u2q20vqsg2JQ6yoE5M54VRmuW_JIBHAIAYVKoy09dxqbrgLbZuJzPNWJqXjwis6EByCHAXlO1K8g7ViUvgPwBBNtgVO44q3rTSZtg5HEDvCkJRIf7RowJf7zstdzWlOpTW-5xUbM89JiXlUYgP2F7K3FZPHo1I7KzawEKUqXiiBr9y7N4ocPZH0ZgqPKqQgSiEY6-i0Ae8ra1m2lhh34tjYgMPY53_5grw76F7Gq-1_Ed6F572r_kV-cTo4_wgvOFXtSHmSqk-wNpvO_WfETjO7Ez3kDrVvFjE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB7SFEKh9D62R6rSvrTgja3D0pa-hE2X9MhSQgP7EowkSxCaeLd79KG_vjO2dzdbQqF9M2Zky6MZ6ZuR9Q3A6ywqkUZvE1lmMZE62sTGnsMoxXinrLU8UkL_aJgfnshPIzXagvfLszANP8Qq4UaeUc_X5OCTMu6tSUN95addYgvT1-C6zFNDNn1wvCaP0rzloExNoqQYrchJ-d667cZydHNiZ6iZ2JS0uApzbkLYeg0a3IbTZe-bX0--dxdz1_W__iB2_N_PuwO3WnDK9htrugtboboHO0ft9vt9mDYpiDqjyM4qNlvgRIOmysaRtQStM0aZXUbn_pm3VJiCzX4sLCUYGG0S4M0pPmx8Yd-x_YqdXU5IsktG-TOwmvn2AZwMPnzrHyZt0YbEI1LUiTVeeGUcD6mMEuELIlChYqld4E5zy33MnREm8NRI6bkIio4DxyjLqEJPioewXY2r8BgYYslc4CKueO6kNdp5nD9ciQEpUf5o0YE3y7ErfMtoToU1zouGi5kXpMSiVmIHXq1kJw2Px5VSuxsmsBKlGl4oga98ubSJAv2Q9GargCqkEEohFOvprAOPGmNZt5YYdeLM2IG39ZD_pQdFf9g_rq-e_IvwC9j5ejAovnwcfn4KNziV7Mh4kqlnsD2fLsJzBE5zt1v7x2-ImRTp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+in+survival+of+patients+with+oral+cavity+squamous+cell+carcinoma%3A+An+international+collaborative+study&rft.jtitle=Cancer&rft.au=Amit%2C+Moran&rft.au=Yen%2C+Tzu-Chen&rft.au=Liao%2C+Chun-Ta&rft.au=Chaturvedi%2C+Pankaj&rft.date=2013-12-15&rft.issn=1097-0142&rft.eissn=1097-0142&rft.volume=119&rft.issue=24&rft.spage=4242&rft_id=info:doi/10.1002%2Fcncr.28357&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon